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Human Fetal Keratocytes Have Multipotent
Characteristics in the Developing Avian Embryo
Jennifer R. Chao,1 Marianne E. Bronner,2 and Peter Y. Lwigale3
The human cornea contains stem cells that can be induced to express markers consistent with multipotency in
cell culture; however, there have been no studies demonstrating that human corneal keratocytes are multipotent.
The objective of this study is to examine the potential of human fetal keratocytes (HFKs) to differentiate into
neural crest-derived tissues when challenged in an embryonic environment. HFKs were injected bilaterally into
the cranial mesenchyme adjacent to the neural tube and the periocular mesenchyme in chick embryos at em-
bryonic days 1.5 and 3, respectively. The injected keratocytes were detected by immunofluorescence using the
human cell-specific marker, HuNu. HuNu-positive keratocytes injected along the neural crest pathway were
localized adjacent to HNK-1-positive migratory host neural crest cells and in the cardiac cushion mesenchyme.
The HuNu-positive cells transformed into neural crest derivatives such as smooth muscle in cranial blood
vessels, stromal keratocytes, and corneal endothelium. However, they failed to form neurons despite their
presence in the condensing trigeminal ganglion. These results show that HFKs retain the ability to differentiate
into some neural crest-derived tissues. Their ability to respond to embryonic cues and generate corneal endo-
thelium and stromal keratocytes provides a basis for understanding the feasibility of creating specialized cells for
possible use in regenerative medicine.
Introduction
Themost common causes of human corneal blindness arevisually significant stromal scarring and endothelial cell
dysfunction. In the United States, the top ranking diseases
requiring corneal transplantation are pseudophakic bullous
keratopathy, Fuch’s endothelial dystrophy, keratoconus, non-
Fuch’s dystrophy, and corneal scarring [1]. In children, con-
genital corneal opacities are the most common indications for
corneal transplantation. At present, keratoplasty, either pen-
etrating, lamellar, or endothelial, is the only effective means of
recovering vision in the conditions stated above. Un-
fortunately, approximately 80% of individuals with visually
significant stromal scarring live in countries without sufficient
health care resources, and these patients often go untreated
[1]. In the United States, donated corneal tissue currently
meets the needs of most affected individuals; however, with
the advent of refractive surgery, the supply of donor corneas
suitable for transplantation is predicted to be significantly
reduced [1]. Additionally, many patients who have under-
gone penetrating keratoplasty reject the transplanted alloge-
neic corneal tissue, and re-operation of failed grafts is the
second most common indication for corneal transplantation
in the United States [1]. Because of these difficulties, there is
increased interest in pursuing the use of cells that have the
ability to self-renew, differentiate into multiple cell lineages,
and remodel tissues in vivo, in the treatment of corneal dis-
orders [2].
Previous studies have isolated subpopulations of human
corneal epithelial and stromal multipotent stem cells by their
ability to efflux Hoechst 33342, a fluorescent dye that leads to
easy fluorescence-activated cell sorting [3–5]. A study by Du
et al. identified a side population (SP) of stem cells in corneal
stroma located in the peripheral region posterior to the Pa-
lisades of Vogt [4]. These cells were rare in number, and after
four passages in primary human corneal culture, the SP cells
comprised 1.3% of the total population. In vitro, the SP cells
expressed ABCG2, an ATP binding cassette transporter,
which has been identified as a specific marker for stem cells
in a number of adult tissues [6–8]. Du et al. (2005) were able
to demonstrate that cultured human stromal SP cells were
capable of expressing keratocyte, cartilage, and glial cell-
specific makers in response to high levels of various growth
factors in vitro. They concluded that the adult human corneal
clonal SP cells retain the potential for differentiation.
While these studies indicate that the human cornea con-
tains stem cells that can be induced to express markers
consistent with multipotency in cell culture, there have been
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no studies indicating that human stromal keratocytes are
multipotent. Our laboratory has reported the ability of quail
keratocytes isolated from late embryos to retain neural crest
progenitor properties by differentiating into stromal kerato-
cytes, corneal endothelium, and other neural crest-derived
tissues [9]. This suggests that stromal keratocytes retain the
multipotency of their neural crest precursors.
The objective of this study is to examine the potential of
human fetal keratocytes (HFKs) to differentiate into neural
crest-derived structures when challenged in an embryonic
environment. Stromal keratocytes isolated from human fetal
corneas were injected along cranial neural crest migratory
pathways and in the periocular mesenchyme in chick
embryos. In the chick embryonic microenvironment, the
injected keratocytes retained multipotentiality and trans-
formed into neural crest derivatives such as smooth muscle
in cranial blood vessels, stromal keratocytes, and corneal
endothelium. However, they failed to form neurons despite
their localization in the condensing trigeminal ganglion.
These results show that HFKs retain the ability to differen-
tiate into other tissues. Their ability to respond to embryonic
cues and generate corneal endothelium and stromal kerato-
cytes provides a basis for understanding the feasibility of
creating specialized cells for possible use in regenerative
medicine to treat corneal wounds and defects.
Materials and Methods
Isolation of stromal keratocytes and culture in vitro
Human donor corneas (approximately 1 month old and
not suitable for human transplantation) obtained from Tissue
Banks International (www.tbionline.org) were dissected un-
der sterile conditions in Ringer’s solution. The use of human
donor tissue was approved by the California Institute of
Technology Committee for Protection of Human Subjects
and in accordance with the tenets of the Declaration of
Helsinki. Trimmed central corneal buttons were digested
with dispase (1.5mg/mL; Roche) for 15min then rinsed in
Ringer’s solution with 0.1% bovine serum albumin (BSA).
The corneal epithelial cell layer was peeled away using fine
forceps, and the endothelium was gently scraped away
leaving only the stroma. Stromal keratocytes were isolated as
described by Conrad and Kawakita [10,11], with some
modifications. In brief, stromal tissue was diced into small
pieces then digested with 0.25% collagenase A (Worthington)
in Ringer’s solution at 37C for approximately 0.5–1 h until
the collagen matrix encasing the stromal keratocytes was
digested. Liberated keratocytes were filtered through a
70 mm nylon cell strainer (BD Falcon), pelleted at 2000 rpm,
and washed twice in defined keratinocyte serum-free me-
dium (KSFM) to remove the collagenase. Cells were re-
suspended in KSFM, seeded on plastic tissue culture dishes,
and incubated at 37C under 5% CO2. KSFM is a serum-free
medium that was previously to propagate and maintain
hepatocytes [12] and keratocytes [11] in vitro.
Preparation of isolated keratocytes
for microinjection
The primary cultures were confluent after incubation of 8
days in KSFM media. After one passage, cells were removed
from plates and separated into single cells by incubation in
balanced salt solution containing 0.25% trypsin/1mM EDTA
at room temperature for 1–5min. The enzymatic reaction
was stopped by addition of a soybean-trypsin inhibitor. Cells
were transferred to centrifuge tubes and spun down at
2000 rpm. The cell pellet was washed three times with large
volumes of Ringer’s solution containing 0.1% BSA, re-
suspended in 6–10mL of the same solution, and then kept on
ice until injected.
Microinjection of HFKs into chick embryos
Fertilized White Leghorn chick (Gallus gallus domesticus)
eggs were obtained from commercial sources. Chick eggs
were incubated at 38C for 30 h to obtain 5- to 7-somite
(HH stages 8–9) [13]. Embryos were prepared as previously
described [14]. Briefly, chick eggs were windowed and the
vitelline membrane removed from the region of injection
using pulled glass needles. HFKs were injected under the
ectoderm alongside both sides of the dorsal neural tube
extending from the region of the caudal diencephalon to the
hindbrain (Fig. 1). In some experiments HFKs were injected
into the periocular region of E3 embryos. Injected embryos
were re-incubated for 0–15 days, n = 10, for each time point.
At the time of injection, 2 mL of cells was resuspended into
1mL of KSFM media and distributed evenly into 6-chamber
slides. The cells were allowed to attach at 37C under 5%
CO2 for 4–6 h.
Immunohistochemical analysis and imaging
Cell cultures were briefly rinsed with Ringer’s solution
then fixed in 4% paraformaldehyde (PFA) for 2 h at room
temperature. Experimental chick embryos were collected in
Ringer’s solution, fixed over night in 4% PFA, and then
embedded in gelatin and cryosectioned at 8–10mm. Fixed cell
cultures and cryosections were prepared for immunostaining
using standard protocols. Briefly, samples were rinsed in
phosphate buffered solution containing 0.1% triton-X (PBT)
and blocked with antibody buffer (PBT containing 0.2% BSA
and 5% heat-inactivated goat serum). To label corneal stro-
mal cells, mouse chondroitin sulfate (IgM; Sigma) was used
diluted 1:200 and rabbit CD34 (IgG; Santa Cruz Biotechnol-
ogy) was used diluted 1:100. Human nuclear antibody
(HuNu; Millipore) was used diluted 1:500 (IgG1) to label all
human cells. HNK-1 (IgM) was used diluted 1:50 to label
migratory neural crest cells. Mouse anti-MF20 (IgG2b,
DHSB) against myosin heavy chain was used diluted 1:3 to
label cardiac muscle, and smooth muscle actin-SMA (IgG2a;
Sigma) was used diluted 1:1000 to label the smooth muscle
lining of blood vessels. Mouse HuC/D (IgG2b; Invitrogen)
was used diluted 1:500 to label neuronal cells, and rabbit
anti-Neurofilament 200 (IgG; Sigma) was used diluted 1:100
to label axons. Rat anti-N-cadherin (IgG; DHSB) was used
diluted 1:3 to label the corneal endothelial cell layer.
Following overnight (1 h at room temperature for cells)
incubation in antibody solution, sections and cell cultures
were extensively rinsed in PBT, blocked, and then incubated
in secondary antibodies. The following secondary antibodies
(Molecular Probes) were used at 1:200; Alexa 594 goat anti-
mouse IgG1, Alexa 488 goat anti-mouse IgG1, Alexa 350 goat
anti-mouse IgM, Alexa 488 goat anti-rat IgG, Alexa 488 goat
anti-rabbit IgG, Alexa 488 goat anti-mouse IgG2a, and Alexa
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350 goat anti-mouse IgG2b. Some sections were counter-
stained with DAPI to show all nuclei. Slides were cover-
slipped with Perma Flour (Immunon) and fluorescent images
were captured using a Zeiss Axiocam mounted on a Zeiss
Axioskop 2 microscope (Zeiss). Images were assembled
using Adobe Photoshop 7.0 (Adobe Systems, Inc.).
Results
Isolation and transplantation of HFKs
To determine the differentiation state of the HFKs at the
time of injection, some cells were allowed to attach in vitro
then examined for morphology and expression of keratocyte
markers. Live attached cells exhibited a flat dendritic mor-
phology with several long interconnecting cellular pro-
cesses (Fig. 1A) that is typical for keratocytes [15].
Immunocytochemistry revealed that the cells stained posi-
tive for the transmembrane protein, CD34. CD34 is expressed
in stromal keratocytes but not in corneal epithelium, endo-
thelium, or human corneal stromal stem cells in vitro [16–18].
CD34 expression is lost in keratocytes that have become
myofibroblastic or fibroblastic in culture [16,19]. In addition,
the cultured cells stained positively for chondroitin sulfate
(Fig. 1C), which has been previously shown to label kerato-
cytes [20]. All cells were positive for both CD34 and chon-
droitin sulfate (Fig. 1D). Furthermore, we found that all cells
stained positive for stromal keratocyte-specific 3G5-defined
ganglioside, but did not stain for N-cadherin, an endothelial
marker (data not shown). Thus, at the time of injection into
chick embryos, cultured HFKs expressed markers that are
characteristic of keratocyte phenotype.
To elucidate their developmental potential, HFKs were
injected bilaterally into the cranial mesenchyme adjacent to
the neural tube of stage 9 (E1.5) chick embryos. In embryos
fixed immediately after injection (0 h, n = 4), aggregates of
cells positively immunostained with the human specific nu-
clear antibody (HuNu) were detected on either side of the
neural tube spanning from the rostral mesencephalon to the
rhombomere 2 (Fig. 1E). Injected cells were in the region of
the endogenous migratory neural crest cells, labeled by the
HNK-1 antibody, but were not themselves positive for the
neural crest marker (Fig. 1F, G).
Injected HFKs co-localize with migratory
neural crest cells
In the cranial region of the developing chick embryo,
neural crest cells exit the dorsal neural tube and migrate
extensively along defined routes [21,22]. To determine
whether the grafted human keratocytes follow the path of
migratory neural crest cells, we examined the embryos at
approximately 20 h following injection. Injected embryos
collected at this time (n= 7) showed bilateral dispersions of
HuNu-positive cells from the injection sites adjacent to the
neural tube (Fig. 1E) into the surrounding cranial region
(Fig. 2A). Cross section through the diencephalic region re-
vealed that HuNu-positive cells co-localized with HNK-1-
positive cells that form the dorsal optic stream of migratory
neural crest cells (Fig. 2B, arrowheads), but were absent from
FIG. 1. Human fetal keratocytes (HFKs) in culture and after injection along migratory pathways of chick neural crest cells.
(A) Phase-contrast image demonstrating the dendritic and elongated morphology typical of normal keratocytes. (B)
Expression of CD34, a transmembrane protein found in keratocytes but not in corneal epithelium or endothelium. (C)
Expression of chondroitin sulfate (CS) in the cytoplasm. (D) Overlay of B and C shows that all cells express both CD34 and
chondroitin sulfate in culture. Cells were counterstained with DAPI to label all nuclei. (E)Whole-mount Stage 9 chick embryo
showing localization of HuNu-positive HFKs adjacent to the dorsal neural tube at time zero. (F and G) Cross section along
the dotted line of the embryo in (E) showing that the injected cells are in the migratory pathway of the endogenous HNK-1-
positive neural crest cells. nt, neural tube.
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the ventral stream (Fig. 2B, arrows). At the midbrain level,
HuNu-positive cells co-localized with the late-migrating
neural crest cells (Fig. 2C, arrowheads) that subsequently
aggregate to form the trigeminal ganglion. However, HuNu-
positive cells were interspersed with the cranial mesenchyme
(Fig. 2C, asterisks) and did not appear to co-localize with, but
they were located adjacent to, the HNK-1-positive cells in the
lateral regions. A similar pattern was observed in the
hindbrain region, although HuNu-positive cells were in-
termixed with the cardiac mesenchyme (Fig. 2D). Our results
show that HFKs injected adjacent to the neural tube either co-
localize with the endogenous migratory neural crest cells or
disperse in the cranial mesenchyme. Approximately 6· 103
cells were introduced per embryo.
HFKs contribute to cranial blood vessels and heart
To determine whether grafted HFKs can acquire different
fates due to signaling from the embryonic environment, we
analyzed their expression of specific differentiation markers
at later stages of development. Transverse sections through
E5 injected embryos contained HuNu-positive cells lining
the cranial blood vessels (Fig. 3A). As cranial blood vessels
and pericytes of ocular vasculature are derived from the
neural crest [21,23–25], the HuNu-positive cells appeared to
migrate to an appropriate neural crest location. They also
expressed the tissue-specific marker, alpha-smooth muscle
actin (a-SMA), consistent with that of the surrounding en-
dogenous pericytes (Fig. 3B, arrows). In contrast, those
HuNu-positive cells that localized in the mesenchyme ad-
jacent to the neural tube did not stain for a-SMA (Fig. 3C),
suggesting that expression in the blood vessels was specific.
Similar to E4, HuNu-positive cells were found in the cranial
blood vessel linings at E7 and demonstrated a-SMA ex-
pression (Fig. 3D, E).
Another derivative of cranial neural crest cells is the car-
diac cushion mesenchyme and the cardiac outflow tracts
[26,27]. Similar to the endogenous neural crest cells, injected
HFKs migrated through the pharyngeal arches and into the
primitive heart region where they localized within the car-
diac cushion mesenchyme between the endocardium and
myocardium (Fig. 3F–H). This mesenchyme is surrounded
by the early developing great vessels, which express a-SMA,
and the myocardium wall, which is MF20 (sarcomeric my-
osin)-positive. Unlike the HuNu-positive cells in the cranial
blood vessel lining, which were positive for a-SMA, the in-
jected cells that migrated into the cardiac cushion mesen-
chyme did not express either a-SMA or MF20. Endogenous
neural crest cells that localize in the cardiac cushion mesen-
chyme do not express a-SMA or MF20 [28] either; however,
we were unable to specifically identify the differentiation
state of these cells due to the lack of good markers for cardiac
cushion cells. Nevertheless, it appears that the injected HFKs
migrated into the cardiac cushion mesenchyme as did the
endogenous neural crest cells. It is therefore possible that
they respond to environmental cues in this region and con-
tribute to cardiac development.
Injected HFKs localize in the trigeminal ganglion
but they do not form neurons
Neural crest cells contribute to sensory and autonomic
ganglia of the peripheral nervous system [29–31]. We ex-
amined the ability of injected HFKs to contribute to the
FIG. 2. Injected keratocytes co-localize with migratory neural crest cells. (A) Stage 12 chick embryo showing dispersed
HuNu-positive HFKs 20 h after injection. Cross sections through different cranial levels showing (B, B¢) HuNu- and HNK-1-
positive cells co-localizing in the optic stream of migratory neural crest cells (arrowheads) and HNK-1-positive cells alone in
the ventral region (arrow); (C, C¢) HuNu- and HNK-1-positive cells co-localizing in the region of the condensing trigeminal
ganglion indicated by HNK-1 staining of the ectoderm (arrowhead), and HuNu-positive cells intermingled with head mes-
enchyme (asterisk); and (D, D¢) HuNu-positive cells co-localizing with the cardiac neural crest and in the cardiac mesenchyme
(asterisk). Sections are counterstained with DAPI to label all nuclei. nt, neural tube; ov, optic vesicle; ht, tubular heart.
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trigeminal ganglia. Since HuNu-positive cells localize with
the presumptive trigeminal ganglion mesenchyme (Fig. 2C),
we examined their ability to differentiate into sensory neu-
rons. HuNu-positive cells were located in the proximal re-
gion of the trigeminal ganglion (Fig. 4A–D), where
endogenous neural crest cells normally form sensory neu-
rons and glia [31]. However, the HuNu-positive cells did not
stain for the neuron-specific markers HuC/D and neurofi-
lament at E5 and E8 (Fig. 4B, D). Our results indicate that
despite the co-localization of injected HFKs with neural crest
cells during gangliogenesis, they do not respond to the
neurogenic environmental cues to form trigeminal sensory
neurons.
HFKs contribute to corneal development
in the chick embryo
Endogenous neural crest cells that form the cornea pause
for about 1 day in the periocular region at E3 before migra-
tion into the eye [32]. In chick, neural crest migration occurs
in two waves, beginning at approximately E4 to form an
endothelial monolayer of cells, and is followed by a second
wave that invades the primary stroma and differentiates into
keratocytes by E6. To determine whether injected HFKs
contribute to the chick cornea, the eye region of host embryos
was examined at developmental stages corresponding to the
times of the neural crest invasion, from E3 through E8. While
HuNu-positive keratocytes could be detected in the migra-
tory pathway leading to the periocular region by E3, only
very few cells were found in the periocular mesenchyme
poised to form the cornea. By E5, no HuNu-positive cells
contributed to forming corneal endothelium, but were in-
stead found in the region of the perilimbal sclera (data not
shown). From this observation, it is possible that the majority
of the HuNu-positive cells did not co-localize with the neural
crest of the presumptive cornea during eye development.
Another possibility is that the HuNu-positive cells prolifer-
ated at a slower rate than the endogenous periocular mes-
enchyme.
To overcome this shortfall and to challenge HFKs in the
embryonic environment of the forming cornea, cells were
injected directly into the space between the lens vesicle and
the overlaying presumptive cornea epithelium at E3 (Fig. 5A,
arrow). By E5, HuNu-positive cells behaved like the endog-
enous neural crest cells and organized in a monolayer be-
tween the lens and ectoderm, characteristic of the corneal
endothelium (Fig. 5E, arrows). In addition, these cells ex-
pressed both the stromal marker chondroitin sulfate and the
FIG. 3. Injected HFKs con-
tribute to cranial blood vessels
and cardiac cushion mesen-
chyme. Section through E5
head demonstrating HuNu-
positive cells in the blood ves-
sels (A) that are positive for
alpha-smooth muscle actin (a-
SMA) (B, arrows), as opposed
to those near the neural tube
(C, arrow). (D, E) Section
through E7 head demonstrat-
ing HuNu-positive cells in the
blood vessel linings that co-
label with a-SMA. (F) Section
through E3 heart demonstrat-
ing HuNu-positive cells in the
region of the developing trun-
cus arteriosis. (G, H) Section
through E5 embryo showing
HuNu-positive cells in the en-
docardial cushion, staining
for neither a-SMA nor MF20
(arrow). rp, Rathke’s pouch; da,
dorsal aorta; nt, neural tube;
ba, branchial artery; ta, trun-
cus arteriosus; cv, common
ventricle; ec, endocardial
cushion.
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endothelial marker N-cadherin (Fig. 5F, arrowheads), al-
though the latter at a lower level than endogenous endo-
thelial expression (Fig. 5F, asterisk). By stage E8, all three
layers of the cornea are formed (Fig. 5G). Corneal stromal
cells have changed from mesenchymal neural crest cells to
exhibiting the thin and elongated morphology characteristic
of keratocytes [33]. Corneal endothelial cells express N-
cadherin, which distinguishes them from the other corneal
layers [34]. In sections of E8 embryos, HuNu-positive cells
were present in both the cornea stroma and endothelium.
HuNu-positive cells in the corneal stroma were positive for
chondroitin sulfate while those in the corneal endothelium
remained N-cadherin-positive, suggesting that HFKs can
respond to environmental cues within the forming eye and
differentiate into appropriate cell types of the cornea.
Discussion
Stromal keratocytes comprise the largest proportion of the
cornea and secrete extracellular matrix proteins that are
crucial to its transparency. Despite the important role of
these cells in vision, most studies are focused on the ability of
human keratocytes to maintain their phenotype in vitro.
Thus, little is known about their regenerative potential. In
this study, we show that when grafted into the embryonic
environment, human stromal keratocytes respond to signals
available to endogenous neural crest cell precursors and can
differentiate into some neural crest-derived tissues, including
cranial blood vessels, corneal endothelium, and keratocytes.
Previous studies have demonstrated that cells other than
keratocytes reside in the mammalian corneal stroma, in-
cluding corneal stromal stem cells [4,35,36]. These multi-
potent mesenchymal stromal cells are present in the
peripheral and limbal cornea and have the ability to differ-
entiate into tissues that are distinct from the ocular mesen-
chymesuchasadipocytes,osteocytes,andchondrocytes[37–39].
A recent study demonstrated that human cornea-derived
precursor cells can be induced to form functional endothelial
cells by retinoic acid and wnt/b-catenin signaling in vitro
[40]. In addition, corneal stromal stem cells have been ob-
served to adopt keratocytic function and characteristics
when injected into mouse corneal stroma [41]. The HFKs
characterized in our study likely represent a distinct popu-
lation from these stem cell populations. They were isolated
from the central cornea, excluding the peripheral and limbal
regions where stem cells have been proposed to reside [4,35].
At the time of injection into the chick embryos, HFKs were
positive for CD34 and chondroitin sulfate markers, which are
expressed by keratocytes, but not corneal fibroblasts, myo-
fibroblasts, or human corneal stromal stem cells in vitro [16–
18]. The combined expression of these makers and their
elongated and dendritic morphologies suggest that HFKs
were keratocytic at the time of injection into the embryos.
Following injection into the cranial region of the chick
embryo, the HuNu-positive cells did not appear to strictly
follow the pathways of the endogenous neural crest cells but
rather dispersed randomly within the cranial mesenchyme
[42,43]. This suggests that the injected keratocytes did not
respond to the same migratory cues, such as semaphorins 3A
and 3F, multiple ephrins, integrins, annexin A6, and BMPs,
that guide neural crest cells to various locations [44–50].
Nonetheless, some HuNu-positive cells co-localized with the
neural crest cells as they ceased to migrate in the regions of
the condensing cranial ganglia, in the ventral region of the
forming cranial blood vessels and heart, and in the perio-
cular region of the forming eye. Only the HuNu-positive
cells that resided along the cranial blood vessels were SMA-
positive, suggesting that they responded to pro-angiogenic
growth factors such as TGFß, PDGF, and VEGF in the vas-
cular environment associated with the formation of myofi-
broblasts [51–54]. Despite their localization in the trigeminal
ganglion, the HFKs did not form neurons. This result con-
firms our previous observation that quail embryonic kera-
tocytes do not differentiate into neurons [9]. Furthermore,
HuNu-positive cells only contributed to the corneal endo-
thelium and stroma when they were directly injected into the
periocular region. Given that the HFKs injected alongside the
neural tube were localized in the periocular region, it is
possible that the HFKs proliferated more slowly than the
endogenous chick cells and became diluted during cornea
development. Within the ocular region, HFKs differentiated
into N-cadherin-positive corneal endothelial cells and also
contributed to the stroma.
Due to the inability of human corneal keratocytes to
maintain their characteristic phenotype in culture, several
studies have identified potential sources for keratocyte dif-
ferentiation. Human bone marrow mesenchymal stem cells
and adipose-derived stem cells have been shown to
FIG. 4. Injected HFKs localize within the developing chick
trigeminal ganglion. E5 (A, B) and E8 (C, D) sections are
immunostained with HuNu to mark HFKs, neuronal peri-
nuclear marker HuC/D, and neuronal axons with neuro-
filament (NF). HuNu-positive cells (arrows) did not stain
positive for the perinuclear neuronal marker HuC/D at E5
or with HuC/D and neurofilament at E8. Vm, maxillo-
mandibular branch of trigeminal ganglion; Vo, ophthalmic
branch of trigeminal ganglion.
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differentiate into keratocyte-like cells in vitro [55,56]. Trans-
planted directly into the cornea stroma of mice, these bone
marrow and umbilical stem cells assumed typical keratocytic
phenotypes [56,57]. Our study demonstrates for the first time
that the stromal keratocytes retain sufficient multi-
potentiality to form several derivatives in addition to kera-
tocytes. They can display characteristics of corneal
endothelial cells, vascular smooth muscle cells, and perhaps
the endocardial cushion mesenchyme. Interestingly, it has
recently been shown that human keratocytes can be repro-
grammed into induced pluripotent stem cells, which,
when injected with a hydrogel, may aid in corneal wound
healing [58].
We utilized keratocytes isolated from 1-month-old corneas
in this study. Upon migration into the region of the pre-
sumptive cornea, neural crest cells down-regulate HNK-1
[59], transform from mesenchymal to fibroblastic morphology
[33], and initiate the expression of molecular markers such as
collagens, keratan sulfate, and chondroitin sulfate [60–63].
During subsequent development, the newly formed kera-
tocytes synthesize the extracellular matrix and maintain the
transparency of the corneal stroma. At birth, the human
FIG. 5. HFKs injected adja-
cent to the periocular mesen-
chyme form early corneal
endothelium and stromal
keratocytes. HFKs were in-
jected between the lens rudi-
ment and presumptive
corneal epithelium at E3,
shown by the arrow in the
contralateral control eye (A).
Cells labeled with HuNu are
shown after injection (B) and
in higher magnification
(C). Note that neither these
cells nor endogenous migrat-
ing neural crest express N-
cadherin at this time. Light
chondroitin sulfate staining is
observed between the corneal
epithelium and lens rudi-
ment. At E5, the endothelial
layer begins to form and it is
N-cadherin positive in the
control eye (D, arrowhead)
and in the injected eye (F, as-
terisk). HFKs incorporate into
the periocular mesenchyme
(E, arrow) and comprise a
monolayer of cells expressing
both N-cadherin and chon-
droitin sulfate (F, arrowheads
and inset). At E8, both the
corneal stroma (G, arrow) and
corneal endothelium (G, ar-
rowhead) are formed. HFKs
incorporate into the corneal
stroma (H) and express
chondroitin sulfate (I, arrows)
and into the corneal endo-
thelium where they express
N-cadherin (I, arrowhead and
inset). Ep, epithelium; L, lens.
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corneas are fully formed and transparent, and the isolated
HFKs exhibited keratocyte characteristics that are different
from the mesenchymal neural crest progenitors. However,
it is possible that tissue age may play an important role in
the multipotentiality of human keratocytes. After birth, the
infant cornea continues to develop by changing the shape of
its curvature, increasing in size, and inverting its horizontal
and vertical dimensions [64,65]. Therefore, fetal keratocytes
may possess the potential to proliferate, unlike the quies-
cent adult keratocytes. Keratocyte density is reduced with
age as demonstrated by in vivo confocal microscopy, and
this reduction appears to be associated with a decreased
density of mitochondria in the remaining keratocytes as
well as changes in the collagen fibrils seen with age [66–69].
Because of the extensive corneal remodeling that occurs
after birth and the continuous changes that occur with ag-
ing, it is possible that stromal keratocytes early in postnatal
development demonstrate more plasticity to embryonic
environmental cues than adult stromal keratocytes.
In conclusion, our results demonstrate that HFKs retain
the ability to form nonocular neural crest derivatives and
corneal endothelium, while also preserving their keratocytic
phenotype upon incorporation into the corneal stroma.
While the necessary embryonic environmental cues need to
be elucidated, our results suggest that fetal human kerato-
cytes may be capable of serving as sources for use in corneal
regenerative cell therapy or tissue engineering.
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